UniProt ID | SMS2_HUMAN | |
---|---|---|
UniProt AC | Q8NHU3 | |
Protein Name | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | |
Gene Name | SGMS2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 365 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein. Golgi apparatus membrane Multi-pass membrane protein. Predominantly plasma membrane, some in Golgi apparatus. Some localization in the perinuclear region where it colocalizes with a sialyltransferase. |
|
Protein Description | Sphingomyelin synthases synthesize the sphingolipid, sphingomyelin, through transfer of the phosphatidyl head group, phosphatidylcholine, on to the primary hydroxyl of ceramide. The reaction is bidirectional depending on the respective levels of the sphingolipid and ceramide. Plasma membrane SMS2 can also convert phosphatidylethanolamine (PE) to ceramide phosphatidylethanolamine (CPE). Major form in liver. Required for cell growth in certain cell types. Regulator of cell surface levels of ceramide, an important mediator of signal transduction and apoptosis. Regulation of sphingomyelin (SM) levels at the cell surface affects insulin sensitivity.. | |
Protein Sequence | MDIIETAKLEEHLENQPSDPTNTYARPAEPVEEENKNGNGKPKSLSSGLRKGTKKYPDYIQIAMPTESRNKFPLEWWKTGIAFIYAVFNLVLTTVMITVVHERVPPKELSPPLPDKFFDYIDRVKWAFSVSEINGIILVGLWITQWLFLRYKSIVGRRFCFIIGTLYLYRCITMYVTTLPVPGMHFQCAPKLNGDSQAKVQRILRLISGGGLSITGSHILCGDFLFSGHTVTLTLTYLFIKEYSPRHFWWYHLICWLLSAAGIICILVAHEHYTIDVIIAYYITTRLFWWYHSMANEKNLKVSSQTNFLSRAWWFPIFYFFEKNVQGSIPCCFSWPLSWPPGCFKSSCKKYSRVQKIGEDNEKST | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
18 | Phosphorylation | EHLENQPSDPTNTYA HHHHCCCCCCCCCCC | 46.59 | 21945579 | |
21 | Phosphorylation | ENQPSDPTNTYARPA HCCCCCCCCCCCCCC | 45.22 | 21945579 | |
23 | Phosphorylation | QPSDPTNTYARPAEP CCCCCCCCCCCCCCC | 22.49 | 21945579 | |
24 | Phosphorylation | PSDPTNTYARPAEPV CCCCCCCCCCCCCCC | 11.59 | 21945579 | |
44 | Phosphorylation | NGNGKPKSLSSGLRK CCCCCCCCHHHHHCC | 41.85 | 23927012 | |
46 | Phosphorylation | NGKPKSLSSGLRKGT CCCCCCHHHHHCCCC | 29.47 | 23403867 | |
47 | Phosphorylation | GKPKSLSSGLRKGTK CCCCCHHHHHCCCCC | 47.33 | 23403867 | |
55 | Ubiquitination | GLRKGTKKYPDYIQI HHCCCCCCCCCCEEE | 62.95 | - | |
56 | Phosphorylation | LRKGTKKYPDYIQIA HCCCCCCCCCCEEEE | 11.68 | 21945579 | |
59 | Phosphorylation | GTKKYPDYIQIAMPT CCCCCCCCEEEECCC | 7.10 | 21945579 | |
66 | Phosphorylation | YIQIAMPTESRNKFP CEEEECCCCCCCCCC | 33.24 | 21945579 | |
68 | Phosphorylation | QIAMPTESRNKFPLE EEECCCCCCCCCCHH | 43.56 | 21945579 | |
71 | Ubiquitination | MPTESRNKFPLEWWK CCCCCCCCCCHHHHH | 47.45 | - | |
116 | Ubiquitination | LSPPLPDKFFDYIDR CCCCCCHHHHHHHHH | 46.09 | 21906983 | |
191 | Ubiquitination | MHFQCAPKLNGDSQA CCEEECCCCCCCHHH | 35.74 | - | |
331 | S-palmitoylation | NVQGSIPCCFSWPLS CCCCCCCEEEECCCC | 3.31 | 19233134 | |
332 | S-palmitoylation | VQGSIPCCFSWPLSW CCCCCCEEEECCCCC | 2.25 | 19233134 | |
343 | S-palmitoylation | PLSWPPGCFKSSCKK CCCCCCCHHHHHHHH | 4.84 | 19233134 | |
348 | S-palmitoylation | PGCFKSSCKKYSRVQ CCHHHHHHHHHHCCC | 5.94 | 19233134 | |
363 | Ubiquitination | KIGEDNEKST----- CCCCCCCCCC----- | 66.70 | 21906983 | |
365 | Phosphorylation | GEDNEKST------- CCCCCCCC------- | 54.41 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SMS2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SMS2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of SMS2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Palmitoylation | |
Reference | PubMed |
"Sphingomyelin synthase 2 is palmitoylated at the COOH-terminal tail,which is involved in its localization in plasma membranes."; Tani M., Kuge O.; Biochem. Biophys. Res. Commun. 381:328-332(2009). Cited for: SUBCELLULAR LOCATION, PALMITOYLATION AT CYS-331; CYS-332; CYS-343 ANDCYS-348, AND MUTAGENESIS OF 331-CYS-CYS-332; CYS-343 AND CYS-348. |